SLC9A1 and cardiac arrest: Recent studies have also shown that NHE1 inhibition protects from multiorgan injury in conditions of whole body ischemic-reperfusion injury and global metabolic acidosis, including cardiac arrest and resuscitation, traumatic hemorrhagic shock, and sepsis [9, 46, 47].